Aldeyra The (ALDX) vs Kalaris Therapeutics Inc (KLRS)
A side-by-side comparison of Aldeyra The and Kalaris Therapeutics Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALDX
Aldeyra The
$0.96HealthcareDelayed quote: Oct 6, 2026, 10:34 AM EDT
KLRS
Kalaris Therapeutics Inc
$2.89HealthcareDelayed quote: Oct 6, 2026, 10:24 AM EDT
Total return — ALDX vs KLRS
growth of $100 · dividends reinvested · last 10yALDX -87.7% (-18.9%/yr)KLRS -99.1% (-37.3%/yr)ALDX compounded faster over this window
Log scale — wide-divergence pair
ALDX KLRS
ALDX vs KLRS: by the numbers
- •KLRS is the larger company ($63M vs $58M market cap).
Metrics side by side
Valuation
| Metric | ALDX | KLRS |
|---|---|---|
| P/B ratio | 1.53 | 1.10 |
Profitability
| Metric | ALDX | KLRS |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -60.85% | -76.75% |
| ROIC | -63.52% | -52.40% |
Growth (annualized)
| Metric | ALDX | KLRS |
|---|---|---|
| Total return CAGR (5Y) | -36.54% | -81.13% |
Frequently asked
- How have ALDX and KLRS total returns compared?
- Over the past 5 years, ALDX delivered -36.54% and KLRS delivered -81.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.